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intellectual deficits and type E brachydactyly typical for clas-
sical AHO syndrome together with distinctive facial dysmor-
phisms not present in the former. Furthermore, one patient 
presented with schizophrenic psychosis, an observation that 
would be in accordance with previous reports about an as-
sociation between schizophrenia susceptibility and an un-
known gene within the chromosomal region 2q37. 
 © 2015 S. Karger AG, Basel 
 Over 115 patients with 2q37 deletion syndrome have 
been reported, being the result of either isolated deletion/
microdeletion or monosomy originating from unbal-
anced translocations [Leroy et al., 2013; Ogura et al., 
2014; Jean-Marcais et al., 2015]. The referred symptoms 
comprise a wide spectrum including intellectual and be-
havioral, skeletal, cardiac, and urogenital anomalies as 
well as Wilms tumor, epilepsy, autism, and eczema. Only 
a fraction of these patients manifest typical symptoms
of intellectual disability and brachydactyly type E [Al-
bright hereditary osteodystrophy (AHO)-like pheno-
type], which is seen in about half of 2q37 monosomic pa-
tients [Leroy et al., 2013]. Since the monogenic brachy-
dactyly mental retardation syndrome (BDMR) is linked 
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 Abstract 
 2q37.3 deletion syndrome belongs to the chromosomal 
2q37 deletion spectrum which clinically resembles Albright 
hereditary osteodystrophy (AHO) syndrome. It is is mainly 
characterized by short stature, obesity, round face, brachy-
dactyly type E, intellectual disability, behavioral problems, 
and variable intellectual deficits. Different from classical 
AHO syndrome, patients with 2q37 deletion syndrome lack 
renal parathyroid hormone resistance (pseudohypopara-
thyroidism) and soft tissue ossification. So far, deletion map-
ping or molecular breakpoint analyses of 2q37 have been 
performed in only few patients. Here, we report on 2 patients 
with 2q37.3 deletion syndrome. In both patients the break-
point of the 5.5-Mb terminal microdeletion could be nar-
rowed down to the same  ∼ 200-kb interval on 2q37.3 by
BAC-FISH and/or array-CGH. Flanking low-copy repeats may 
indicate a classical microdeletion syndrome genesis for the 
2q37.3 microdeletion subgroup. Clinical evaluation revealed 
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to dominant mutations in the  HDAC4 gene on 2q37, mi-
crodeletion syndrome 2q37 is considered to be a contigu-
ous gene syndrome encompassing the  HDAC4 gene as 
well as possibly several other neighboring genes [Wil-
liams et al., 2010].
 Although clinical findings are mostly well-document-
ed, molecular analyses of monosomy 2q37 breakpoints 
with either FISH or microsatellite panels refining the 
monosomic region are only performed in a minority of 
cases. With respect to the variety of symptoms and pre-
sumed inter-individual differences in the cytogenetic 
condition, clear phenotype-genotype conclusions are 
very limited at present.
 Within the 2q37 deletion spectrum, deletion size as 
well as deletion origin of the reported cases vary widely, 
including unbalanced translocations, terminal and inter-
stitial deletions, thus encompassing a rather inhomoge-
neous molecular cytogenetic group. The 2q37.3 deletion 
syndrome presents a subclass of the 2q37 deletion spec-
trum.
 Here, we report on 2 further unrelated cases of 2q37.3 
deletion with the AHO-like phenotype and intriguing fa-
cial dysmorphism. Both patients show true interstitial 
microdeletions assigned to an identical breakpoint in 
2q37.3. We could localize the deletion breakpoints within 
flanking low-copy repeats, being suggestive for a classical 
microdeletion syndrome genesis [Stankiewicz and Lup-
ski, 2010]. Associated clinical features are described and 
discussed referring to previous reports of 2q37 deletion 
syndrome patients.
 Case Report 
 Case 1 
 The 18-year-old woman presented with symptoms of a para-
noid schizophrenic psychosis at the psychiatric hospital. Psy-
chotic symptoms had first occurred only few months prior to 
hospitalization. A mild intellectual impairment with develop-
mental delay and learning disability had been observed since ear-
ly childhood. Her intelligence had been measured in the lower 
normal range of learning disability; however, she earned a sec-
ondary school degree followed by a 3-year apprenticeship and 
finished with a diploma.
 Facial features were a round face, hypoplastic midface with flat 
nasal bridge, small, deep set eyes, and mildly dysmorphic, deep set 
ears. Additionally, facial hypertrichosis and medial flaring of the 
bushy eyebrows were remarkable ( fig. 1 A, B). Physical examina-
tion showed brachydactyly type E in both hands with inhomoge-
neous shortening of phalanges and metacarpals and especially 
short and broad distal phalanges of the thumbs ( fig. 1 C). The toes 
were short, but there was no obvious type E brachydactyly in the 
feet ( fig. 1 D). Fingers and toes showed nail anomalies with very 
short, everted rims or ingrown nails ( fig. 1 C, D). Further physical 
features were myopia, pectus excavates, and uterus bicornis.
 The family history was unremarkable besides a unilateral 
broadening and duplication of the terminal phalanx and nail of a 
thumb in 1 of 2 otherwise inconspicuous elder brothers.
 Case 2 
 The 32-year-old male patient presented with mild intellectual 
disability and severe obesity, the latter starting at the age of 12 
years. Psychomotor and intellectual delay had required ergother-
apy and special schooling. Puberty had been delayed due to hypo-
gonadism leading to testosterone substitution from the age of 15 
until the age of 20. The patient required special school education. 
Neither was he able to graduate with a degree nor to learn a profes-
sion; he was still living at his mother’s home and was unable to take 
responsibility for his own life.
A B C D
 Fig. 1. Case 1.  A ,  B Round face, hypoplastic midface with flat nasal 
bridge, broad nasal tip, small, deep set eyes, and mildly dysmor-
phic, deep set ears, facial hypertrichosis, and medial flaring of the 
bushy eyebrows.  C Brachydactyly type E in both hands with inho-
mogeneous shortening of phalanges and metacarpals, especially 
short and broad distal phalanges of the thumbs.  D Short toes with 
no obvious type E brachydactyly in the feet. Side findings: slight 
partial syndactyly of toes II and III and fingers ( C ) and toes ( D ) 
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 The patient showed striking facial dysmorphism exhibiting a 
round face, pronounced midface hypoplasia with flattened nasal 
bridge, deep set small eyes, which appeared almost squinted, hy-
pertelorism, and mildly dysmorphic ears. A deep frontal hair line 
and general hypertrichosis of the upper facial area were observed; 
the eyebrows showed medial flaring and appeared rather bushy 
being in contrast to the sparse beard growth ( fig. 2 A, B).
 Physical examination revealed brachydactyly type E with short-
ening of metacarpal bones III–V as well as various phalanges in 
both hands ( fig. 2 C, D). The feet did not show apparent brachy-
dactyly but were rather small (5–10th percentile) in comparison to 
the body length of 180 cm; bilaterally there was a relative over-
length of the second toes ( fig. 2 E). Further skeletal findings com-
prised additional bone dysplasia with abnormal bending of various 
long bones especially of the upper limbs (ulnar and radial bending) 
causing limited mobility and flexion contracture of the elbows. 
Other physical features were severe obesity with associated skin 
ulcers (lipedema), micropenis, unilateral testical maldescensus, 
and sparse pubic hair.
 On the primary assumption of AHO syndrome, biochemical 
Gs-alpha analysis had been performed giving normal results. Fam-
ily history covering 3 generations was inconspicuous. However, 
only limited information could be gained. Both parents had 
reached rather low educational levels, thus mild intellectual deficit 
or learning disability have not been excluded. One elder brother 
and one younger half-brother of the maternal side were referred to 
as unsuspicious and had reached lower school degrees and profes-
sional education. Unfortunately, chromosome analyses of the par-
ents and other family members could not be performed.
 Within short time after genetic presentation, the patient sus-
tained paraplegia due to vertebral damage caused by an unclear 
bone marrow inflammation. He died unexpectedly at the age of 34 
years as a result of a non-resolved infection.
 Results 
 Conventional chromosome analysis on a 550 band 
level showed a normal 46,XX and 46,XY karyotype in 
case 1 and 2, respectively. In patient 2, a microdeletion 
22q11.2 was excluded by FISH analysis, but FISH using 
2q subtelomeric probes (2q TelVysion; Abott Molecu-
lar) detected a heterozygous terminal microdeletion 
2q37 in both cases. Further iterative BAC-FISH analyses 
with clones obtained from CHORI (http://bacpac.chori.
org) localized the chromosomal breakpoint in 2q37.3 
within an  ∼ 200-kb interval marked by BAC RP11-
124E11 (chr2: 237,550,004–237,731,201, present in both 
cases) and BAC RP11-713K19 (chr2: 237,699,779–
237,864,624, deleted in both cases) (hg19, Feb. 2009) 
( fig. 3 ). Additional array-CGH analysis (CytoChip Oli-
go ISCA 4×180K; BlueGnome, Cambridge, UK) in
case 1 revealed a karyotype arr 2q37.3(237,720,284–
242,951,149)×1 (Ensembl Release 64), thus confirming 
the breakpoint region at approximately 237.7 Mb ± 100 
kb ( fig. 3 ).
 Conventional chromosome and BAC-FISH analyses 
in both parents of patient 1 as well as in her brother car-
rying the thumb duplication revealed a normal chromo-
somal constitution and excluded the 2q37.3 microdele-
tion in each case.
 Notably, both the breakpoint-flanking or -spanning 
BAC clones RP11-124E11 and RP11-713K19 as well as a 
third, more proximally located BAC, RP11-260J21 (chr2: 
237,375,335–237,556,067; hg19), showed cross-hybrid-
A B C D E
 Fig. 2. Case 2.  A ,  B Round face, pronounced midface hypoplasia 
with flattened nasal bridge, broad nasal tip, deep set eyes with nar-
row palpebral fissures, hypertelorism, mildly dysmorphic ears, 
deep frontal hair line, hypertrichosis of the upper facial area, me-
dial flaring of the bushy eyebrows in contrast to the sparse beard 
growth.  C ,  D Brachydactyly type E with shortening of metacarpal 
bones III-V as well as various phalanges in both hands.  E Feet with-
out brachydactyly but rather small with bilaterally slight shorten-
ing of the first metatarsal bone pronounced by the relative over-
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ization to regions elsewhere in the genome of the 2 pa-
tients, their analyzed relatives, and another unrelated, 
chromosomally normal individual. These secondary 
FISH signals may indicate the presence of segmental du-
plications with at least 1 copy in the breakpoint region. 
Further support for this interpretation is provided by re-
ports on CNVs in this region (copy number gains 
nssv581030, 706961, and 707006 of uncertain signifi-
cance in the Database of Genomic Variants DGV; http://
dgv.tcag.ca).
 Discussion 
 Both patients showed a characteristic and intriguingly 
similar facial phenotype, clinically being the major diag-
nostic feature in combination with the type E brachydac-
tyly. However, despite of the identical breakpoint region, 
clinical variability was evident ( table 1 ). 
 The presented cases provide further support for the 
molecular assignment of clinical symptoms observed in 
2q37.3 deletion syndrome.
 Based on our patients as well as reported individuals 
with similar chromosomal breakpoints [Leroy et al., 
A B C
D
 Fig. 3. For case 1 ( A ) and case 2 ( B ), FISH experiments localized 
the deletion breakpoint to an  ∼ 200-kb interval on 2q37.3 marked 
by BAC RP11-124E11 (green, present in both cases) and BAC 
RP11-713K19 (red, deleted in both cases). In both cases, secondary 
FISH signals from BAC RP11-713K19 in 2q31 (arrowheads) were 
visible.  C FISH in case 1 using more proximally breakpoint-flank-
ing BACs RP11-201F21 (green) and RP11-260J21 (red), where 
RP11–260J21 showed cross-hybridization to 1p36, as well as in 
case 2 (not shown). Cross hybridization of RP11-713K19 and 
RP11-260J21 suggests the presence of segmental duplications in 
the 2q37.3 breakpoint region with paralogous blocks elsewhere in 
the genome.  D 2q37 deletion map of patients 1 and 2 from our 
study together with the position of RefSeq genes in the region and 
the localization of BAC probes used in our FISH experiments (hu-
man Feb. 2009 assembly GRCh37/hg19; http://genome.ucsc.edu). 
We further included del(2)(q37.3) patient 7 from a previously
published study [Leroy et al., 2013] showing a similar deletion 
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2013], we would like to highlight the characteristic and 
rather specific facial dysmorphism of 2q37.3 deletion 
syndrome. Especially typical features hereby are the 
round flat face with deep set, small (squinted) eyes, flat 
nasal root, facial hirsutism, and heavy eyebrows.
 Chromosomal deletion or microdeletion of 2q37 was 
first reported in AHO-like syndrome by Wilson et al. 
[1995]. Since then, a number of cases with terminal 2q37 
deletions have been reported, varying widely in deletion 
size and only partly sharing the AHO-like syndrome phe-
notype. Brachydactyly type E is one of the main features 
of AHO-like and BDMR syndrome. The identification of 
individuals with characteristic findings and point muta-
tions in the  HDAC4 gene located on 2q37 at 240.1 Mb 
(hg19) could demonstrate that the  HDAC4 gene is caus-
ative for brachydactyly type E and BDMR [Williams et al., 
2010]. Among reported cases of 2q37 deletion, depending 
on the deletion size and localization with respect to 
 HDAC4 ,  brachydactyly may be present or absent.
 In a series of 20 cases with 2q37 monosomy of different 
chromosomal causes, including interstitial and terminal 
deletions as well as unbalanced chromosome transloca-
tions, no common breakpoint had been identified, thus 
leading to the hypothesis of a genesis other than low-copy 
repeat mediated [Aldred et al., 2004]. In contrast to this 
observation, we identified approximately identical break-
points in 2 AHO-like-syndrome patients. The same 
breakpoint furthermore had already been reported in at 
least 1 further AHO-like patient [Leroy et al., 2013], hint-
ing to a distinct chromosomal region in 2q37 that is struc-
turally prone to chromosomal breakage or deletion. Our 
observation of secondary FISH signals from the break-
point-flanking or -spanning probes ( fig. 3 A–C) suggests 
that the deletion breakpoints in the 2 patients presented 
here could be localized in a region enriched with segmen-
tal duplications. It can be speculated that this feature may 
be associated with increased genomic instability [Stankie-
wicz and Lupski, 2010], thus representing a possible cause 
for an increased risk of recurrent chromosome breakage 
in the subgroup of patients with 2q37 deletion syndrome 
with breakpoints at approximately 239–240 Mb (hg 19). 
Since typical features of the 2q37 deletion syndrome like 
facial characteristics, brachydactyly, and variable cogni-
tive impairment were present in all 3 cases of the small 
2q37.3 microdeletion, the 2q37 core phenotype might be 
caused by the small interstitial deletion interval. These 
results hint to the existence of a true, clinically well-de-
fined interstitial microdeletion syndrome 2q37.3 which is 
merged up within the larger group of 2q37 deletion syn-
drome. This phenomenon is comparable to other micro-
deletion syndromes like e.g. Xp22.3 microdeletion syn-
drome, being a specific interstitial microdeletion with 
distinct phenotypic features encompassed by the large 
group of different Xp deletion phenotypes [Li et al., 1992; 
Stankiewicz and Lupski, 2010].
 However, despite the shared 200-kb breakpoint inter-
val and common basic phenotype, clinical variability was 
evident in our patients. While patient 1 did not suffer 
from signs of generalized osteodystrophy, patient 2 clear-
ly exhibited pronounced osteodystrophic features with 
extended skeletal dysplasia besides brachydactyly. Obe-
sity was also only seen in patient 2, whereas sternal defor-
mity was a feature only in patient 1. The intellectual im-
pairment, though unequivocal when compared to the 
family, was only mild to moderate in both cases, enabling 
a simple school degree and professional education in the 
Table 1.  Comparison of clinical features of our patients with the 
only patient (P7) described in the literature so far showing a simi-
lar breakpoint region
Case 1 Case 2 P7 [Leroy et 
al., 2013]
Psychotic symptoms +





Brachydactyly type E + +
Broad distal phalanges of the 
thumbs + +
Small feet +
Overlength of the second toes +
Short toes + +
Bone dysplasia +
Nail anomalies +
Round face + +
Hypoplastic midface + +
Flat nasal bridge + + +
Small, deep set eyes + +
Hypertelorism +
Dysmorphic ears + +
Facial hypertrichosis + +
Deep frontal hairline + +




Skin ulcers (lipedema) +
Micropenis +
Unilateral testical maldescensus +
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young woman but special school education without de-
gree and without the ability of self-contained living in 
case 2. Intellectual deficits, osteodystrophy, sternal anom-
alies, and obesity are reported findings in patients with 
2q37 deletion syndrome showing rather high variability 
even in familial cases.
 Acute schizophrenic psychosis had occurred in one of 
the microdeletion patients, which in contrast to autism so 
far has not been described as a feature of 2q37 deletion 
spectrum. According to the WHO International Classifi-
cation of Diseases (ICD) 10 and the Fifth Edition of the 
Diagnostic and Statistical Manual of Mental Disorders 
(DSM-V), autism spectrum disorders and schizophrenic 
psychosis are considered different disease entities, even 
though increased comorbidity in part of the autism spec-
trum diseases – Asperger autism but not typical child-
hood Kanner autism – suggests common basic patho-
mechanisms [Simonoff et al., 2008; King and Lord, 2011]. 
The occurrence of schizophrenic psychosis in patient 1 is 
of special interest, since the chromosomal region 2q37 
previously had been reported as one of several schizo-
phrenia susceptibility loci [Paunio et al., 2001; Wijsman 
et al., 2003; Klei et al., 2005]. Though the linkage was ob-
tained in small genetic isolates, this might indicate an un-
known gene in 2q37.3 being associated with schizophre-
nia. Taking into account the overall high frequency of 
schizophrenic psychosis in the general population, coin-
cidental occurrence due to another possibly genetic dis-
position is as well possible.
 Altogether, the presented cases provide further sup-
port for the molecular assignment of clinical symptoms 
observed in 2q37.3 deletion syndrome. In addition, the 
2q37.3 deletion associated phenotype might be extended 
to a possible susceptibility for schizophrenia, being in ac-
cordance with former linkage studies.
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